key: cord-0724418-72m2atfd
authors: John Omo-Osagie, Uhomoibhi; Shode, Francis Oluwole; Kehinde Ademola, Idowu; Sabiu, Saheed
title: Molecular modelling identification of phytocompounds from selected African botanicals as promising therapeutics against druggable human host cell targets of SARS-CoV-2
date: 2022-04-12
journal: J Mol Graph Model
DOI: 10.1016/j.jmgm.2022.108185
sha: 736210e23cc41cb87c5de6f51322dccf6e6d1423
doc_id: 724418
cord_uid: 72m2atfd

The coronavirus disease 2019 (COVID-19), caused by the Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2), is highly pathogenic and transmissible. It is mediated by the binding of viral spike proteins to human cells via entry and replication processes involving human angiotensin converting enzyme-2 (hACE2), transmembrane serine protease (TMPRSS2) and cathepsin L (Cath L). The identification of novel therapeutics that can modulate viral entry or replication has been of research interest and would be germane in managing COVID-19 subjects. This study investigated the structure-activity relationship inhibitory potential of 99 phytocompounds from selected African botanicals with proven therapeutic benefits against respiratory diseases focusing on SARS-CoV-2's human cell proteins (hACE2, TMPRSS2, and Cathepsin L) as druggable targets using computational methods. Evaluation of the binding energies of the phytocompounds showed that two compounds, Abrusoside A (−63.393 kcal/mol) and Kaempferol-3-O-rutinoside (−58.939 kcal/mol) had stronger affinity for the exopeptidase site of hACE2 compared to the reference drug, MLN-4760 (−54.545 kcal/mol). The study further revealed that Verbascoside (−63.338 kcal/mol), Abrectorin (−37.880 kcal/mol), and Friedelin (−36.989 kcal/mol) are potential inhibitors of TMPRSS2 compared to Nafamostat (−36.186 kcal/mol), while Hemiphloin (−41.425 kcal/mol), Quercetin-3-O-rutinoside (−37.257 kcal/mol), and Myricetin-3-O-galactoside (−36.342 kcal/mol) are potential inhibitors of Cathepsin L relative to Bafilomycin A1 (−38.180 kcal/mol). The structural analysis suggests that these compounds do not compromise the structural integrity of the proteins, but rather stabilized and interacted well with the active site amino acid residues critical to inhibition of the respective proteins. Overall, the findings from this study are suggestive of the structural mechanism of inhibitory action of the identified leads against the proteins critical for SARS-CoV-2 to enter the human host cell. While the study has lent credence to the significant role the compounds could play in developing potent SARS-CoV-2 candidate drugs against COVID-19, further structural refinement, and modifications of the compounds for subsequent in vitro as well as preclinical and clinical evaluations are underway.

The coronavirus disease 2019 , caused by the Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2), is highly pathogenic and transmissible. The first identified and reported case of COVID- 19 Although, some vaccines have been approved and are currently in use, the vaccination program itself is riddled with problems including, misinformation and disinformation about the effectiveness of the various vaccines that are available, reduced potency against the variants, and post-vaccination symptoms, such as thromboembolism and thrombocytopenia and other adverse effects [3] . Hence, the development of novel drug candidates that can stand the test of time in offering therapeutics that will be globally acceptable, affordable, and easily accessible, is imperative. Drug development from plants has been demonstrated against several debilitating diseases including viral infections [4-5] and recent reports have lent credence to exploration of plant secondary metabolites as leads against druggable targets in SARS-CoV-2 infection using computational approaches [6] [7] [8] .

As part of the human host cell proteins, important druggable targets including the human angiotensin converting enzyme 2 (hACE2), transmembrane protease serine 2 (TMPRSS2), and cathepsin L (Cath L), are required to facilitate and aid the viral entry and replication in SARS-CoV-2 infection. Specifically, infection with SARS-CoV-2 occur when the interaction between the viral spike protein and the human host cell is facilitated through processes involving hACE2, TMPRSS2 and Cath L [9] . In fact, the inhibitory effect of the depletion of hACE2 and TMPRSS2 on SARS-CoV-2 replication in different cell lines has been reported [10] . Similarly, the expression of Cath L is up-regulated during chronic inflammation as observed with cytokine storm in COVID-19 infection and is also implicated in extracellular matrix degradation, a critical process for SARS-CoV-2 viral entry into the host cell [11] . Generally, the host cell proteins are genetically more stable than viral structural proteins, which are also typical druggable targets on the viral genome [12, 13] . Hence, the development of novel phytotherapeutics that can modulate viral entry or replication through inhibition of hACE2, TMPRSS2, and Cath L would be of immense benefit to mankind as we grapple with the COVID-19 pandemic.

To identify Phytocompounds as potential therapeutic agents against SARS-CoV-2 and its associated target proteins, several in silico and in vitro studies have explored the potentials of African rich plants.

Dwarka et al. [14] , reported four compounds (Uzarin, Hypoxide, L-canavanine and arabic acid) from J o u r n a l P r e -p r o o f South African medicinal plants as potent therapeutics against COVID-19 in an in silico study [14] .

Similarly, Amaranthin from Amaranthus tricolor commonly used in Nigeria, Kenya and Tanzania was reported to be a potential inhibitor of the main protease enzyme of SARS-CoV-2 [15] . Compounds such as licoleafol, methyl rosmarinate, A-terpineol, P-cymene, T-anethole, and thyhydromoquinone are some of the other therapeutics that have been identified from African medicinal plants against the main protease, hACEE-2 and other key druggable targets of SARS-CoV-2 [15 -21] . As part of the ongoing efforts to develop anti-SARS-CoV-2 drugs, the current study adopted a computational structure-activity relationship approach exploring 99 plant secondary metabolites from eight African medicinal plants (Leonotis leonurus, Ocimum gratissimum, Macaranga barteri, Abrus precatorius, Artemisia afra, Carapa procera, Alepidea amatymbica, and Drosera madagascariensis) with proven therapeutic benefits against respiratory diseases and related infections [22 -30] , against the SARS-CoV-2 host cell targets.

The protein structures of the hACE2 (PDB ID: 1R4L), TMPRSS2 (PDB ID: 5CE1) and Cath L (PDB ID: 5MQY) were obtained from the RSCB Protein Data Bank (https://www.rcsb.org). The preparation of all the protein structures were carried out on the UCSF Chimera version 1.14 by eliminating water molecules, nonstandard naming, and protein residue connectivity [31] . Prior to molecular docking, protein structures with missing atoms in their sidechains and protein backbone are rectified by adding such missing atoms. The reference/standard drugs as well as the phytocompounds used in this study were accessed and downloaded from PubChem [32] . Using Avogadro software [33] , the 3-D structures of the selected 99 phytochemicals (Supplementary   Table S1 ) and reference drugs [bafilomycin A1 (BFA), nafamostat (NFM), and MLN 4670 (MLN)] were all prepared in readiness for docking. While BFA was used as a known Cath L inhibitor, NFM and MLN were adopted as potent inhibitors of TMPRSS2 and hACE2, respectively [34 -36] .

For the molecular docking, the Autodock package on Chimera version 1.14 was used with default parameters [8] . Briefly, to the ligands were added Gasteiger charges and all the hydrogen atoms that are non-polar were joined to carbon atoms. Docking of all prepared secondary metabolites (ligands) into the binding site of the respective proteins (hACE2, TMPRSS2, and Cath L) by defining the grid box with a spacing of 1 Å each and size (26 × 24 × 25) , (60 × 76 × 68) and (50 × 40 × 46) pointing in x, y and z J o u r n a l P r e -p r o o f directions, respectively. The resulting complex with the best geometric pose in each case was thereafter subjected to molecular dynamics (MD) simulation.

The MD simulations were done as earlier reported [8] with the AMBER 18 suite Leap module [37] where hACE2 protein was numbered from residues 19 to 615, while Cath L, and TMPRSS2 proteins were numbered from residues 1 to 220 and 1 to 370, respectively. ANTECHAMBER was used to generate atomic partial charges for the ligands by utilizing the Restrained Electrostatic Potential (RESP) and the General Amber Force Field (GAFF) procedures. The Leap module of AMBER 18 allowed for the addition of hydrogen atoms, Na + and Clcounter ions for the three proteins, respectively, to neutralize all systems. Thereafter, the systems were anchored within an orthorhombic box of TIP3P water molecules within 10 Å [38] , allowing a stepwise heating 0 -300 K (50 ps) and a pressure of 1 bar [39] . The total time for the MD simulations conducted was 100 ns. In each simulation, the SHAKE algorithm was employed to constrict hydrogen atoms' bonds [40] .

For the post-dynamic analysis of root mean square fluctuation (RMSF), root mean square deviation (RMSD), and radius of gyration (RoG), the CPPTRAJ module was adopted [41] , and the resulting plots were generated in Origin V1.4 [42] . For the binding affinity, the binding free energy, Molecular Mechanics/GB Surface Area method (MM/GBSA) was estimated over 1 x10 5 snapshots drawn from the 100 ns trajectory [43] .

An assessment of the chemistry and drug likeness of the lead phytocompounds was done using the SwissADME online software [44] .

The results of the molecular docking of the 99 phytocompounds investigated against hACE2, TMPRSS2, and Cath L in this study are presented in supplementary Table S1 . Molecular docking enables the assessment of the geometric fitness and affinity of a molecule upon its binding at the active site of the receptor and the higher the negative score, the better the pose and interaction of the compound with the protein [45, 46] . For hACE2 (Table S1), 16 phytocompounds had docking scores between -10.1 to -9.1 kcal/mol and better affinity for the protein compared to the reference standard, MLN-4760 with a docking score of -7.3 kcal/mol (Table S1 ). For TMPRSS2 (Table S1), 11 phytocompounds had docking scores between -9.2 to -7.9 kcal/mol compared to -8.1 kcal/mol for the reference standard, NFM while for Cath J o u r n a l P r e -p r o o f L (Table S1) kcal/mol were identified as prominent compounds against Cath L (Tables 3 and S4 ). The results suggest that HPN is the best inhibitor against Cath L as it showed higher binding affinity relative to BFA and other compounds used in this study. The observations noted regarding the binding energy values of the tested compounds against hACE2, TMPRSS2 and Cath L are similar with previous reports [47, 48] , where compounds with the highest negative binding energy values were proposed as having the best affinity for SARS-CoV-2 host cell proteins and suggested as potential inhibitors of the respective druggable target. ΔEelec electrostatic energy, ΔEvdW van der Waals energy, ΔGbind total binding free energy, ΔGsolv solvation free energy, and ΔGgas gas-phase free energy.

The inhibitory characteristics of the promising or lead compounds, judging by their binding affinities and those of the respective reference standards against the evaluated targets as a function of interactions with the amino acid residues at the active site of each protein are presented in Figures 1 to 3 . Different degrees of bond interactions such as van der Waals (vdW) overlaps, halogen, hydrogen bonds, alkyl, π-alkyl, π-π stacked interaction, and π-π T-shaped were observed. Specifically, Figure 1 revealed that ABA bound strongly to hACE2 with 4 conventional hydrogen bonds (with Gly187, Glu190, Asn192 and Lys544) and and right (R-)), and between the two domains, is a V-shaped active site cleft on which the L-and Rdomain catalytic residues C25 and H163 are positioned [51] , and the ligands binds at this active site. For

Cath L, the ligand-interaction plot revealed that the reference standard, BFA had a total of 11 interactions consisting of 4 π-alkyl interactions with Met70, Leu69, Ala210, and Ala135, 2 conventional hydrogen bonds, as well as 5 van der Waals forces (Figure 3) . Unlike the BFA, the study compounds (MOG, QOR and HPN) had higher number of hydrogen bonds in addition to van der Waals forces. Furthermore, BFA did not show any π-alkyl interaction with the protein as observed with the three study compounds. Thus, of the three studied ligands (MOG, QOR and HPN), HPN by virtue of the increased number of electrostatic interactions exhibited, will have better binding affinities than the reference drug BFA. This finding is affirmed by the fact that the magnitude of the binding is a measure of how strong the interactions are between the ligand and the protein, and this is usually increased by interactions such as van der Waals forces, electrostatic interactions, and hydrogen bond between two molecules [49] . Table 6 ). The RMSD plots revealed that both BFA and MOG complexes at approximately 55 ns induced unstable conformational changes on the protein structure as evidenced by the relatively high RMSD values ( Figure 6a) . Although, the result of the binding energy suggests that the phytochemicals might be effective inhibitors of Cath L, however, the inhibition mechanism displayed by HPN and QOR may differ to that of BFA and MOG. Generally, the observations on the RMSD values and patterns for the druggable targets in this study are good indications of the test compounds as prospective drug candidates judging by their values which were < 3.5 Å acceptable limit and agrees with a previous study [54] , where plant secondary metabolites induced significant structural stability at the druggable sites of SARS-CoV-2.

J o u r n a l P r e -p r o o f The RoG is a parameter used to evaluate the structural compactness of proteins when they bind with molecules [55] . A lower and higher RoG values indicate more stable and unstable systems, respectively [56] . The hACE-2 RoG plot results correlates with its RMSD plot revealing the that binding of the molecules do not alter the hACE-2 structural stability. Figure 4b as well as Table 5 The SASA plot measures the exposure of the protein structure to solvent environment, and the lower the SASA value, the more exposed the hydrophobic amino acid residues of the proteins are, and the systems stability also increases [57] . From Figure 4c and , Table 5 ), which is an indication of increased exposure of hydrophobic amino acid residues of TMPRSS2, suggestive of increased structural stability. However, the binding of ABC (17032.312 Å 2 ) showed no effect on the exposure of the hydrophobic residues of TMPRSS2 to solvent environment and the overall observation regarding the SASA values of the TMPRSS2 complexes in this study agrees with those of RMSD and RoG following binding of VBS, FDL, and ABC and a further attestation that, the structural integrity, which is significant for inhibitory activity of TMPRSS2, was not compromised. It was J o u r n a l P r e -p r o o f The RMSF is an assessment of how the amino acid residues of a receptor move or fluctuates as a result of a binding of a drug [50, 59, 60] . Increased RMSF value is an indication of increase in flexible movements of the alpha-carbon atoms [8] . Table 6 ).

J o u r n a l P r e -p r o o f As shown in Table 7 , nine compounds including the standards (KOR, VBS, ABC, QOR, MOG, HPN, NFM, BFA, and MLN) are either moderately soluble or soluble in water. This will enhance the bioavailability of the nine compounds. Four compounds (ABA, FDL, ABC, and HPN) passed the druglikeness test. Lipinski's rule of five is a tool used in assessing the drug-likeness compounds whereby a determination is made as to whether any compound that possesses certain pharmacological activities has oral drug properties that will allow it to be administered in humans [61] . On the other hand, VBS, KOR, QOR and MOG did not pass Lipinski's by violating three rules.

All the compounds and reference standards except for ABC and MLN were predicted to exhibit low gastrointestinal tract absorption (GIT). Nevertheless, low GIT absorption does not alter the therapeutic activity of drugs as many drugs (such as Nafamostat, Bafilomycin A1, and Lopinavir) with low GIT absorption are commercially available and therapeutically potent. The level and rate at which the active moiety or metabolite enters systemic circulation are measured by drug bioavailability [61] . Compared with the reference standards, four compounds, KOR, VBS, QOR, and MOG exhibited low bioavailability scores of 0.17, while the bioavailability scores predicted for the other compounds (ABA, FDL, ABC, HPN) and the three reference standards was 0.55.

The modulation of the entry steps and inhibition of these host cell druggable targets could help achieve the inhibition of the viral entry by preventing the interactions between the host cell and the viral proteins.

In this study, two compounds (ABA and KOR) have strong affinity for the exopeptidase site of hACE2, interacted tenaciously with the essential amino acid residues (Glu384, Asn376, His383, Arg496, Thr329, Asp364) needed for the catalytic activity of hACE2. The study further revealed each of the three compounds [(VBS, FDL and ABC) and (QOR, MOG and HPN)] as potential inhibitors of TMPRSS2 and Cath L proteins, respectively, as they do not compromise the structural integrity of the proteins, but rather stabilized and established catalytic interactions with the vital amino residues needed for inhibition of the respective targets. In a nutshell, the results obtained in this study are suggestive of the structural mechanisms of inhibition of the identified leads against the proteins critical for SARS-CoV-2 to enter the human host cell and cause infection. Further refinement and development of the compounds for subsequent in vitro and other preclinical and clinical evaluations are underway.

The data used to support the findings of this study are included within the article.

The authors declare that they have no known competing financial interests or personal relationships that could have appeared to influence the work reported in this paper.

MRC) under a Self-Initiated Research Grant. The views and opinions expressed are those of the authors and do not necessarily represent the official views of the funders.

SS conceptualized and supervised the study. UJO, IKA and SS generated and analyzed the data. SFO cosupervised the project, while UJO wrote the manuscript. All authors read and contributed to critical review of the manuscript for intellectual content and approved the submission for publication.

Additional data for the molecular docking are presented in the supplementary file (Supplementary Table  S1 , S2, S3 and S4). 

Phytotherapeutic evidence against coronaviruses and prospects for COVID

COVID-19 prophylaxis efforts based on natural antiviral plant extracts and their compounds

Repurposing drugs and identification of inhibitors of integral proteins (spike protein and main protease) of SARS-CoV-2

Analysis of therapeutic targets for SARS-CoV-2 and discovery of potential drugs by computational methods

A SARS-CoV-2 protein interaction map reveals targets for drug repurposing

Cathepsin L in COVID-19: From pharmacological evidences to genetics

Nafamostat mesylate blocks activation of SARS-CoV-2: new treatment option for COVID-19

Cellular host factors for SARS-CoV-2 infection

Identification of potential SARS-CoV-2 inhibitors from South African medicinal plant extracts using molecular modelling approaches

Structural basis of SARS-CoV-2 3CL pro and anti-COVID-19 drug discovery from medicinal plants

An overview of key potential therapeutic strategies for combat in the COVID-19 battle

Pharmacological and toxicological properties of Nigella sativa

Molecular docking, simulation and MM-PBSA studies of nigella sativa compounds: a computational quest to identify potential natural antiviral for COVID-19 treatment

Identification of compounds from Nigella sativa as new potential inhibitors of 2019 novel coronavirus (COVID-19): molecular docking study

Therapeutic potentials of antiviral plants used in traditional African medicine with COVID-19 in focus: A Nigerian perspective

A review on molecular docking analysis of phytocompounds against SARS-CoV-2 druggable targets

Chemical constituents of Abrus precatorius

Identification of compounds from the plant species Alepidea amatymbica active against HIV

Antimicrobial, anti-J o u r n a l P r e -p r o o f inflammatory and genotoxicity activity of Alepidea amatymbica and Alepidea natalensis (Apiaceae)

Phytochemicals content, screening and antioxidant/pro-oxidant activities of Carapa procera (barks) (Meliaceae)

Flavonoids as chemotaxonomic markers in the genus

Leonotis leonurus: A herbal medicine review

Chemical constituents, in vitro antimicrobial and cytotoxic potentials of the extracts from Macaranga barteri Mull-Arg

Diversity, phytochemical and medicinal potential of the genus Ocimum L. (Lamiaceae)

Artemisia afra, a controversial herbal remedy or a treasure trove of new drugs

UCSF Chimera, MODELLER, and IMP: an integrated modeling system

PubChem substance and compound databases

Avogadro: An advanced semantic chemical editor, visualization, and analysis platform

Analysis of where and which types of proteinases participate in lysosomal proteinase processing using bafilomycin Al and Helicobacter pylori Vac A toxin

The TMPRSS2 inhibitor Nafamostat reduces SARS-CoV-2 pulmonary infection in mouse models of COVID-19

The interaction of the severe acute respiratory syndrome coronavirus 2 spike protein with drug-inhibited angiotensin converting enzyme 2 studied by molecular dynamics simulation

A five-site model for liquid water and the reproduction of the density anomaly by rigid, nonpolarizable potential functions

Effects of temperature control algorithms on transport properties and kinetics in molecular dynamics simulations

Numerical integration of the cartesian equations of motion of a system with constraints: molecular dynamics of nalkanes

PTRAJ and CPPTRAJ: Software for processing and analysis of molecular dynamics trajectory data

OriginPro 9.1: Scientific data analysis and graphing software-software review

MMGBSA as a tool to understand the binding affinities of filamin-peptide interactions

Drug design workshop: A web-based educational tool to introduce computer-aided drug design to the general public

Astaxanthin-mediated bacterial lethality: Evidence from oxidative stress contribution and molecular dynamics simulation

Docking and scoring in virtual screening for drug discovery: methods and applications

Design and synthesis of pyrazolone-based compounds as potent blockers of SARS-CoV-2 viral entry into the host cells

In silico identification of potential natural product inhibitors of human proteases key to SARS-CoV-2 infection

A mechanism for ion selectivity in potassium channels: computational studies of cation-pi interactions

Phenolics profiling of Carpobrotus edulis (L.) NE Br. and insights into molecular dynamics of their significance in type 2 diabetes therapy and its retinopathy complication

Caught in the act: the crystal structure of cleavedcathepsin L bound to the active site of Cathepsin L. Federation of European Biochemical Societies

Methods of protein structure comparison

How molecular size impacts RMSD applications in molecular dynamics simulations

The dual role of phytochemicals on SARS-CoV-2 inhibition by targeting host and viral proteins

Radius of gyration as an indicator of protein structure compactness

Broadening the horizon: Integrative pharmacophore-based and cheminformatics screening of novel chemical modulators of mitochondria ATP synthase towards interventive Alzheimer's disease therapy

Solvent accessible surface area approximations for rapid and accurate protein structure prediction

Chemical constituents from Limonium tubiflorum and their in silico evaluation as potential antiviral agents against SARS-CoV-2

Natural phytocompounds as possible noncovalent inhibitors against SARS-CoV2 protease: computational approach

MDAnalysis: A toolkit for the analysis of molecular dynamics simulations

Experimental and computational approaches to estimate solubility and permeability in drug discovery and development settings

The authors specially acknowledge the financial assistance of the Directorate of Research and Postgraduate Support, Durban University of Technology, and the Centre for High Performing Computing (CHPC), Cape Town, South Africa for providing the computing platform for this study. Research reported in this publication was also supported by the South African Medical Research Council (SA

• The in silico effect of metabolites of African plants was evaluated against host cell targets of SARS-CoV-2 • Two metabolites had stronger affinity for the exopeptidase site of hACE2 relative to standard • Three of the metabolites each were inhibitors of TMPRSS2 and Cathepsin L • The identified metabolites stabilized and interacted well with the active site amino acid residues critical to inhibition of the targets • The findings would guide structural modification of the metabolites as novel inhibitors of host cell targets of SARS-CoV-2 J o u r n a l P r e -p r o o f

☒ The authors declare that they have no known competing financial interests or personal relationships that could have appeared to influence the work reported in this paper.☐The authors declare the following financial interests/personal relationships which may be considered as potential competing interests:J o u r n a l P r e -p r o o f